The DOI matches its Crossref record; 102 of the 106 references it cites were found in a registry or an index.
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Open accessAbstract
In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similarities to both SARS-CoV and MERS-CoV viruses, and some of the clinical features are shared between COVID-19 and previously identified beta-coronavirus infections. Available evidence indicate that the so called "cytokine storm" an uncontrolled over-production of soluble markers of inflammation which, in turn, sustain an aberrant systemic inflammatory response, is a major responsible for the occurrence of ARDS. Chemokines are low molecular weight proteins with powerful chemoattractant activity which play a role in the immune cell recruitment during inflammation. This review will be aimed at providing an overview of the current knowledge on the involvement of the chemokine/chemokine-receptor system in the cytokine storm related to SARS-CoV-2 infection. Basic and clinical evidences obtained from previous SARS and MERS epidemics and available data from COVID-19 will be taken into account.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically associated with the illness.”
From Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up (2021) · cites this paper as Coperchini et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,243
Cited by
Sorted by citations
Items 201–300 of 1,000
Yang, Y., Cai, Z., & Zhang, J. (2021) · Bioscience Reports · doi:10.1042/bsr20203584 · Cited by 55
Meeran, M. F. N., Javed, H., Sharma, C., Goyal, S. N., Kumar, S., Jha, N. K., & Ojha, S. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05990 · Cited by 57
Potential Effects of Coronaviruses on the Liver: An Update
Wang, X., Lei, J., Li, Z., & Yan, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.651658 · Cited by 56
Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19
Islam, F., Bibi, S., Meem, A. F. K., Islam, M. M., Rahaman, M. S., Bepary, S., Rahman, M. M., Rahman, M. M., Elzaki, A. A., Kajoak, S. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312638 · Cited by 55
A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19)
Karampoor, S., Zahednasab, H., Farahmand, M., Mirzaei, R., Zamani, F., Tabibzadeh, A., Bouzari, B., Ajdarkosh, H., Nikkhah, M., Hashemi, M. R., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107684 · Cited by 54
Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets
Kim, Y., Yu, K.-M., Koh, J., Kim, E.-H., Kim, S., Kim, E. J., Casel, M. A. B., Rollon, R., Jang, S., Song, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27717-3 · Cited by 54
Brown, B., Ojha, V., Fricke, I., Al-Sheboul, S. A., Imarogbe, C., Gravier, T., Green, M., Peterson, L., Koutsaroff, I. P., Demir, A. N., et al. (2023) · Vaccines · doi:10.3390/vaccines11020408 · Cited by 55
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies
Longo, M., Caruso, P., Maiorino, M. I., Bellastella, G., Giugliano, D., & Esposito, K. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01090-9 · Cited by 54
Holuka, C., Merz, M. P., Fernandes, S. B., Charalambous, E. G., Seal, S. V., Grova, N., & Turner, J. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145094 · Cited by 55
Khinda, J., Janjua, N. Z., Cheng, S. S. Y., van den Heuvel, E. R., Bhatti, P., & Darvishian, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26411 · Cited by 53
Salah, H. M., Sharma, T., & Mehta, J. L. (2020) · Cureus · doi:10.7759/cureus.10837 · Cited by 53
Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection
Robinson, F. A., Mihealsick, R. P., Wagener, B. M., Hanna, P., Poston, M. D., Efimov, I. R., Shivkumar, K., & Hoover, D. B. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00681.2020 · Cited by 55
Jain, S., Batra, H., Yadav, P., & Chand, S. (2020) · Vaccines · doi:10.3390/vaccines8040649 · Cited by 54
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection
Hashemi, S. M. A., Thijssen, M., Hosseini, S. Y., Tabarraei, A., Pourkarim, M. R., & Sarvari, J. (2021) · Archives of Virology · doi:10.1007/s00705-021-05070-6 · Cited by 56
Köhler, T., Schwier, E., Praxenthaler, J., Kirchner, C., Henzler, D., & Eickmeyer, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312786 · Cited by 55
Liu, J., Wan, M., Lyon, C. J., & Hu, Y. (2020) · Theranostics · doi:10.7150/thno.47982 · Cited by 53
Gut Microbiota Modulation as a Potential Target for the Treatment of Lung Infections
Cruz, C. S., Ricci, M. F., & Vieira, A. T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.724033 · Cited by 55
Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells
Hafezi, B., Chan, L., Knapp, J. P., Karimi, N., Alizadeh, K., Mehrani, Y., Bridle, B. W., & Karimi, K. (2021) · Cells · doi:10.3390/cells10071761 · Cited by 52
Montenegro, F., Unigarro, L., Paredes, G., Moya, T., Romero, A., Torres, L., López, J. C., González, F. E. J., Pozo, G., López‐Cortés, A., et al. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1820329 · Cited by 53
Balagholi, S., Dabbaghi, R., Eshghi, P., Mousavi, S. A., Heshmati, F., & Mohammadi, S. (2020) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2020.102993 · Cited by 51
Patel, S., Saxena, B., & Mehta, P. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06158 · Cited by 51
Böszörményi, K. P., Stammes, M. A., Fagrouch, Z. C., Kiemenyi-Kayere, G., Niphuis, H., Mortier, D., van Driel, N., Nieuwenhuis, I. G., Vervenne, R. A. W., Haaksma, T., et al. (2021) · Viruses · doi:10.3390/v13081673 · Cited by 52
Advancement in biosensors for inflammatory biomarkers of SARS-CoV-2 during 2019–2020
Garg, M., Sharma, A. L., & Singh, S. B. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112703 · Cited by 50
Nashiry, M. A., Sumi, S. S., Islam, S., Quinn, J. M. W., & Moni, M. A. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa426 · Cited by 50
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Malinowska, B., Baranowska‐Kuczko, M., Kicman, A., & Schlicker, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041986 · Cited by 50
Multisystem inflammatory syndrome in children (MISC): A systematic review
Guimarães, D., Pissarra, R., Reis‐Melo, A., & Guimarães, H. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14450 · Cited by 50
He, D., Yuan, M., Dang, W., Bai, L., Yang, R., Wang, J., Ma, Y., Liu, B., Liu, S., Zhang, S., et al. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103409 · Cited by 50
Wang, Y., Lu, C. C., Li, H., Qi, W., Ruan, L., Bian, Y., Shi, H., Song, H., Tu, S., Zhang, Y., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113888 · Cited by 50
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
Jarlhelt, I., Nielsen, S. K., Jahn, C. X. H., Hansen, C. B., Pérez‐Alós, L., Rosbjerg, A., Bayarri‐Olmos, R., Skjoedt, M., & Garred, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767981 · Cited by 50
Post COVID-19 Vaccination-Associated Neurological Complications
Assiri, S. A., Althaqafi, R. M. M., Alswat, K., Alghamdi, A., Alomairi, N. E., Nemenqani, D. M., Ibrahim, Z. S., & Elkady, A. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s343438 · Cited by 49
Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment
Witika, B. A., Makoni, P. A., Mweetwa, L. L., Ntemi, P. V., Chikukwa, M. T. R., Matafwali, S. K., Mwila, C., Mudenda, S., Katandula, J., & Walker, R. B. (2020) · Molecules · doi:10.3390/molecules25245952 · Cited by 49
Risk stratification by long non‐coding RNAs profiling in COVID‐19 patients
Cheng, J., Zhou, X. P., Feng, W., Jia, M., Zhang, X., An, T., Luan, M., Pan, Y., Zhang, S., Zhou, Z., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16444 · Cited by 48
The Relationship Between Vitamin D and Infections Including COVID-19: Any Hopes?
Taha, R., Abureesh, S., Alghamdi, S., Hassan, R., Cheikh, M., Bagabir, R. A., Almoallim, H. M., & Abdulkhaliq, A. A. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s317421 · Cited by 53
Khalil, A., Tazeddinova, D., Aljoumaa, K., Kazhmukanbetkyzy, Z. A., Оразов, А. Ж., & Toshev, A. D. (2021) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2021.26.3.241 · Cited by 49
Exposome-based public health interventions for infectious diseases in urban settings
Andrianou, X. D., Pronk, A., Galea, K. S., Stierum, R. H., Loh, M. M., Riccardo, F., Pezzotti, P., & Makris, K. C. (2020) · Environment International · doi:10.1016/j.envint.2020.106246 · Cited by 48
Horspool, A. M., Kieffer, T. W., Russ, B. P., DeJong, M. A., Wolf, M. A., Karakiozis, J. M., Hickey, B. J., Fagone, P., Tacker, D. H., Bevere, J. R., et al. (2021) · mSphere · doi:10.1128/msphere.01324-20 · Cited by 48
Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
Shah, T., Shah, Z., Yasmeen, N., Baloch, Z., & Xia, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909011 · Cited by 49
Luo, W., Zhang, J., Zhang, W., Lin, Y., & Wang, Q. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26156 · Cited by 47
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
Freitas, A. T., Calhau, C., Antunes, G., Araújo, B. S. G. D. S. P., Bandeira, M., Barreira, S. C., Bazenga, F., Bráz, S., Caldeira, D., Santos, S. C. R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99952-z · Cited by 47
Sharma, V. K., Prateeksha, Singh, S. P., Singh, B. N., Rao, C. V., & Barik, S. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00874 · Cited by 47
Thrombosis and COVID-19: The Potential Role of Nutrition
Τσούπρας, Α., Lordan, R., & Zabetakis, I. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.583080 · Cited by 46
Samad, A., Jafar, T., & Rafi, J. H. (2020) · Genomics · doi:10.1016/j.ygeno.2020.09.002 · Cited by 46
Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19
Parkinson, N., Rodgers, N., Fourman, M. H., Wang, B., Zechner, M., Swets, M. C., Millar, J. E., Law, A. S., Russell, C. D., Baillie, J. K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-79033-3 · Cited by 47
The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury
Zarrilli, G., Angerilli, V., Businello, G., Sbaraglia, M., Traverso, G., Fortarezza, F., Rizzo, S., Gaspari, M. D., Basso, C., Calabrese, F., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020974 · Cited by 46
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
Baby, K., Maity, S., Mehta, C. H., Suresh, A., Nayak, U. Y., & Nayak, Y. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173922 · Cited by 45
Dyavar, S. R., Singh, R., Emani, R., Pawar, G. P., Chaudhari, V. D., Podany, A. T., Avedissian, S. N., Fletcher, C. V., & Salunke, D. B. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111794 · Cited by 45
Shen, Y. H., Anwar, T. B., & Mulchandani, A. (2021) · Sensors and Actuators Reports · doi:10.1016/j.snr.2021.100025 · Cited by 44
Hardy, E., & Fernández-Patrón, C. (2021) · Biomolecules · doi:10.3390/biom11030390 · Cited by 49
Balkrishna, A., Haldar, S., Singh, H., Roy, P., & Varshney, A. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s298242 · Cited by 44
Vella, R., Panci, D., Carini, F., Malta, G., Vieni, S., David, S., Albano, G. D., Puntarello, M., Zerbo, S., & Argo, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1682306 · Cited by 47
Horiuchi, S., Oishi, K., Carrau, L., Frere, J. J., Møller, R., Panis, M., & tenOever, B. R. (2021) · Science Immunology · doi:10.1126/sciimmunol.abm3131 · Cited by 45
Parisi, G. F., Carota, G., Castruccio Castracani, C., Spampinato, M., Manti, S., Papale, M., Di Rosa, M., Barbagallo, I., & Leonardi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052465 · Cited by 43
Bui, L. T., Winters, N. I., Chung, M.-I., Joseph, C., Gutierrez, A. J., Habermann, A. C., Adams, T. S., Schupp, J. C., Poli, S., Peter, L. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24467-0 · Cited by 45
Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort
Pons, M. J., Ymaña, B., Mayanga-Herrera, A., Sáenz, Y., Alvarez‐Erviti, L., Tapia-Rojas, S., Ojeda, R. G., Blanco, A. B., Moncunill, G., & Ugarte-Gil, M. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700921 · Cited by 44
Al-Karmalawy, A. A., Soltane, R., Elmaaty, A. A., Tantawy, M. A., Antar, S. A., Yahya, G., Chrouda, A., Pashameah, R. A., Mustafa, M., Mraheil, M. A., et al. (2021) · Vaccines · doi:10.3390/vaccines9111317 · Cited by 43
The Coronavirus pandemic – 2022: Viruses, variants & vaccines
Alexandridi, M., Mazej, J., Palermo, E., & Hiscott, J. B. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.02.002 · Cited by 44
Brave, H., & MacLoughlin, R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176435 · Cited by 43
Commonalities Between COVID-19 and Radiation Injury
Rios, C. I., Cassatt, D. R., Hollingsworth, B. A., Satyamitra, M. M., Tadesse, Y., Taliaferro, L. P., Winters, T. A., & DiCarlo, A. L. (2020) · Radiation Research · doi:10.1667/rade-20-00188.1 · Cited by 43
Singh, V. K., Chaurasia, H., Kumari, P., Som, A., Mishra, R., Srivastava, R., Naaz, F., Singh, A., & Singh, R. K. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1946716 · Cited by 43
Tomerak, S., Khan, S., Almasri, M., Hussein, R., Abdelati, A. A., Aly, A. M., Salameh, M. A., Aldien, A. S., Naveed, H., Elshazly, M. B., et al. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13097 · Cited by 43
Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19
Klouda, C. B., & Stone, W. L. (2020) · Antioxidants · doi:10.3390/antiox9090894 · Cited by 42
Balkrishna, A., Solleti, S. K., Verma, S., & Varshney, A. (2020) · Molecules · doi:10.3390/molecules25215091 · Cited by 42
Long-chain polyphosphates impair SARS-CoV-2 infection and replication
Ferrucci, V., Kong, D.-Y., Asadzadeh, F., Marrone, L., Boccia, A. S., Siciliano, R., Criscuolo, G., Anastasio, C., Quarantelli, F., Comegna, M., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abe5040 · Cited by 44
Johnson, B. S., & Laloraya, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.014 · Cited by 42
A comprehensive review on potential therapeutics interventions for COVID-19
Chugh, H., Awasthi, A., Agarwal, Y., Gaur, R. K., Dhawan, G., & Chandra, R. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173741 · Cited by 44
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19
Bruzzone, C., Conde, R., Embade, N., Mato, J. M., & Millet, Ó. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1111482 · Cited by 43
Cytokine Response in SARS-CoV-2 Infection in the Elderly
Sherwani, S., & Khan, M. W. A. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s276091 · Cited by 41
Molinaro, R., Pastò, A., Taraballi, F., Giordano, F., Azzi, J. A., Tasciotti, E., & Corbo, C. (2020) · Nanomaterials · doi:10.3390/nano10112301 · Cited by 41
COVID-19 enters the expanding network of apolipoprotein E4-related pathologies
Gkouskou, K. K., Vasilogiannakopoulou, T., Andreakos, E., Davanos, N., Gazouli, M., Sanoudou, D., & Eliopoulos, A. G. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101938 · Cited by 43
Rotoli, B. M., Barilli, A., Visigalli, R., Ferrari, F., & Dall’Asta, V. (2021) · Biomedicines · doi:10.3390/biomedicines9091220 · Cited by 43
Circular RNAs in human diseases
Wang, Y., Zhang, J., Yang, Y. S. H., Liu, Z., Sun, S., Li, R. F., Zhu, H., Tian, L., Zheng, J., Li, J., et al. (2024) · MedComm · doi:10.1002/mco2.699 · Cited by 41
Candesartan could ameliorate the COVID-19 cytokine storm
ELKAHLOUN, A. G., & Saavedra, J. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110653 · Cited by 40
Kronemberger, G. S., Carneiro, F. A., de Rezende, D. F., & Baptista, L. S. (2020) · Artificial Organs · doi:10.1111/aor.13880 · Cited by 40
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
Aigner, L., Pietrantonio, F., de Sousa, D. M. B., Michael, J., Schuster, D., Reitsamer, H. A., Zerbe, H., & Studnicka, M. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.610132 · Cited by 40
Deng, K., Fan, Q., Yang, Y., Deng, X., He, R., Tan, Y., Lan, Y., Deng, X., Pan, Y., Wang, Y., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26793 · Cited by 40
Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach
Ebrahimi, M., Norouzi, P., Aazami, H., & Moosavi‐Movahedi, A. A. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.095 · Cited by 43
Hänel, A., & Carlberg, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020911 · Cited by 40
Gusev, E., Sarapultsev, A., Hu, D., & Черешнев, В. А. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147582 · Cited by 42
Hu, Z., Lv, Y., Xu, C., Sun, W., Chen, W., Peng, Z., Chen, C., Cui, X., Jiao, D., Cheng, C., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00355 · Cited by 39
Mukherjee, S., Banerjee, B., Karasik, D., & Frenkel‐Morgenstern, M. (2021) · Viruses · doi:10.3390/v13030402 · Cited by 38
Wu, M., Ma, L., Xue, L., Zhu, Q., Zhou, S., Dai, J., Yan, W., Zhang, J., & Wang, S. (2021) · Genomics · doi:10.1016/j.ygeno.2021.08.012 · Cited by 41
Correlation between inflammatory parameters and pituitary–thyroid axis in patients with COVID-19
Ilera, V., Delfino, L. C., Zunino, A., Glikman, P., Drnovsek, M., Reyes, A., Dios, A., Toibaro, J., Pachioli, V., Lannes, N., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02863-2 · Cited by 39
Bachmaier, K., Stuart, A., Singh, A., Mukhopadhyay, A., Chakraborty, S., Hong, Z., Wang, L., Tsukasaki, Y., Maienschein‐Cline, M., Ganesh, B. B., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c09762 · Cited by 39
Quéromès, G., Destras, G., Bal, A., Regue, H., Burfin, G., Brun, S., Fanget, R., Morfin, F., Valette, M., Trouillet‐Assant, S., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1872351 · Cited by 41
Urvashi, U., Kumar, J. B. S., Das, P., & Tandon, V. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00444 · Cited by 38
Dutta, D., Liu, J., & Xiong, H. (2022) · PubMed Central · Cited by 38
Vitamin D, the immune system, and its relationship with diseases
Şanlıer, N., & Guney-Coskun, M. (2022) · Egyptian Pediatric Association Gazette · doi:10.1186/s43054-022-00135-w · Cited by 38
Hammoudeh, S. M., Hammoudeh, A. M., Bhamidimarri, P. M., AlSafar, H. S., Mahboub, B. H., Künstner, A., Busch, H. S., Halwani, R., Hamid, Q. A., Rahmani, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.595150 · Cited by 38
Rajamanickam, A., Kumar, N. P., Padmapriyadarsini, C., Nancy, A., Selvaraj, N., Karunanithi, K., Munisankar, S., Shrinivasa, B., Renji, R. M., Ambu, T. C., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.07.029 · Cited by 38
The rapid adaptation of SARS-CoV-2–rise of the variants: transmission and resistance
Soh, S. M., Kim, Y., Kim, C., Jang, U. S., & Lee, H.-R. (2021) · The Journal of Microbiology · doi:10.1007/s12275-021-1348-5 · Cited by 39
microRNAs as new possible actors in gender disparities of Covid‐19 pandemic
Pontecorvi, G., Bellenghi, M., Ortona, E., & Carè, A. (2020) · Acta Physiologica · doi:10.1111/apha.13538 · Cited by 37
Mousavi, S. Z., Rahmanian, M., & Sami, A. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104610 · Cited by 37
MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity
Vega, M. A., Simón‐Fuentes, M., de la Aleja, A. G., Nieto, C., Colmenares, M., Herrero, C., Domínguez‐Soto, Á., & Corbí, A. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603507 · Cited by 37
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19
Lenti, M. V., Aronico, N., Pellegrino, I., Boveri, E., Giuffrida, P., de Andreis, F. B., Morbini, P., Vanelli, L., Pasini, A., Ubezio, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77945-8 · Cited by 38
Naltrexone a potential therapeutic candidate for COVID-19
Choubey, A., Dehury, B., Kumar, S., Medhi, B., & Mondal, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1820379 · Cited by 36
The Weight of Obesity in Immunity from Influenza to COVID-19
Andrade, F. B., Gualberto, A. C. M., REZENDE, C. P. D., Percegoni, N., Gameiro, J., & Hottz, E. D. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.638852 · Cited by 37
Aucoin, M., Cardozo, V., McLaren, M. D., Garber, A., Remy, D., Baker, J., Gratton, A., Kala, M. A., Monteiro, S., Warder, C., et al. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100115 · Cited by 37
Alefishat, E. A., Jelinek, H. F., Mousa, M., Tay, G. K., & AlSafar, H. S. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.01.007 · Cited by 39
Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19
Darazam, I. A., Kazempour, M., Pourhoseingholi, M. A., Hatami, F., Rabiei, M. M., Gharehbagh, F. J., Amirdosara, M., Hajiesmaeili, M., Shabani, M., Shokouhi, S., et al. (2022) · Blood Purification · doi:10.1159/000524606 · Cited by 36
Zarkoob, H., Allué‐Guardia, A., Chen, Y., Garcia‐Vilanova, A., Jung, O., Coon, S. L., Song, M. J., Park, J., Oladunni, F. S., Miller, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03753-7 · Cited by 37
Metadata
- Authors
- Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M.
- Affiliations
- Istituti Clinici Scientifici Maugeri (IT)
- University of Pavia (IT)
- Corresponding author
- Rotondi, Mario
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 53
- Pages
- 25-32
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC7211650
- OpenAlex
- W3021577619
- Cited by
- 1,288
- References
- 106
- Citations by year
- 2026: 20 · 2025: 44 · 2024: 92 · 2023: 158 · 2022: 274 · 2021: 443 · 2020: 257
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- cytokine storm, COVID-19 pandemic, SARS-CoV-2, chemokines, chemokine receptors, acute respiratory distress syndrome, systemic inflammation, immune cell recruitment, SARS, MERS, betacoronaviruses, disease severity
- MeSH terms
- Betacoronavirus, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Pneumonia, Viral, Coronavirus Infections, Chemokines, Receptors, Chemokine, Severe Acute Respiratory Syndrome, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
